<?xml version="1.0" encoding="utf-8"?>
<Bundle xmlns="http://hl7.org/fhir">
	<id value="bundle-InlytaTabletsEN" />
	<meta>
	<lastUpdated value="2022-03-04T00:00:00Z" />
	<profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi" />
	</meta>
	<identifier>
		<system value="https://leaflet.healthcare/sid/doc" />
		<value value="L000InlytaTabletsEN" />
	</identifier>
	<type value="document" />
	<timestamp value="2021-04-01T00:00:00.000Z" />
	<entry>
		<fullUrl value="Composition/composition-InlytaTabletsEN" />
		<resource>
			<Composition>
				<id value="composition-InlytaTabletsEN" />
				<meta>
				<profile
					value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi" />
				</meta>
				<language value="en" />
				<text>
					<status value="generated" />
					<div xmlns="http://www.w3.org/1999/xhtml">
						<p>electronic Product Information (ePI) document</p>
					</div>
				</text>
				<identifier>
					<system value="https://leaflet.healthcare/sid/composition" />
					<value value="C000composition-InlytaTabletsEN" />
				</identifier>
				<version value="1" />
				<status value="final" />
				<type>
					<coding>
						<system value="https://spor.ema.europa.eu/v1/lists/100000155531/terms/" />
						<code value="100000155538" />
						<display value="Package Leaflet" />
					</coding>
					<text value="Package Leaflet" />
				</type>
				<date value="2021-04-01T00:00:00.000Z" />
				<subject>
					<reference value="MedicinalProductDefinition/inlyta-1mg" />
				</subject>
				<subject>
					<reference value="MedicinalProductDefinition/inlyta-3mg" />
				</subject>
				<subject>
					<reference value="MedicinalProductDefinition/inlyta-5mg" />
				</subject>
				<subject>
					<reference value="MedicinalProductDefinition/inlyta-7mg" />
				</subject>
				<author>
					<reference value="Organization/PfizerEuropeMAEEIG" />
				</author>
				<title value="Inlyta - 1mg, 5 mg Film coated tablets - EN" />
				<section>
					<title value="PACKAGE LEAFLET" />
					<text>
						<status value="generated" />
						<div xmlns="http://www.w3.org/1999/xhtml">
							<h1 style="text-align: center;">Package leaflet: Information for the patient</h1>
							<p style="text-align: center;"><strong>Inlyta 1 mg film-coated tablets</strong></p>
							<p style="text-align: center;"><strong>Inlyta 3 mg film-coated tablets</strong></p>
							<p style="text-align: center;"><strong>Inlyta 5 mg film-coated tablets</strong></p>
							<p style="text-align: center;"><strong>Inlyta 7 mg film-coated tablets</strong></p>
							<p style="text-align: center;">axitinib</p>
							<p>Read all of this leaflet carefully before you start taking this medicine because it
								contains important information for you.</p>
							<ul>
								<li>Keep this leaflet. You may need to read it again.</li>
								<li>If you have any further questions, ask your doctor, pharmacist or nurse.</li>
								<li>This medicine has been prescribed for you only. Do not pass it on to others. It may
									harm them, even if their signs of illness are the same as yours.</li>
								<li>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes
									any possible side effects not listed in this leaflet. See section 4.</li>
							</ul>
							<h2>What is in this leaflet</h2>
							<ol>
								<li>What Inlyta is and what it is used for</li>
								<li>What you need to know before you take Inlyta</li>
								<li>How to take Inlyta</li>
								<li>Possible side effects</li>
								<li>How to store Inlyta</li>
								<li>Contents of the pack and other information</li>
							</ol>
						</div>
					</text>
				</section>

				<section>
					<title value="1. What Inlyta is and what it is used for" />
					<text>
						<status value="generated" />
						<div xmlns="http://www.w3.org/1999/xhtml">
							<p>Inlyta is a medicine containing the active substance axitinib. Axitinib reduces the blood
								supply to the tumour and slows down the growth of cancer.</p>
							<p>Inlyta is indicated for the treatment of advanced kidney cancer (advanced renal cell
								carcinoma) in adults, when one prior drug treatment for this disease has not worked.</p>
							<p>If you have any questions about how this medicine works or why this medicine has been
								prescribed for you, ask your doctor.</p>
						</div>
					</text>
				</section>

				<section>
					<title value="2. What you need to know before you take Inlyta" />
					<text>
						<status value="generated" />
						<div xmlns="http://www.w3.org/1999/xhtml">
							<p><b>Do not take Inlyta:</b></p>
							<p>If you are allergic to axitinib or any of the other ingredients of this medicine (listed
								in section 6).</p>
							<p>If you think you may be allergic, ask your doctor for advice.</p>
							<p><b>Warnings and precautions</b></p>

							<p><b>Talk to your doctor or nurse before taking Inlyta</b></p>

							<ul>
								<li><b>If you have high blood pressure.</b></li>
							</ul>
							<p>Inlyta can raise your blood pressure. It is important to check your blood pressure before
								you take this medicine, and regularly while you are taking it. If you have high blood
								pressure (hypertension) you may be treated with medicines to reduce the blood pressure.
								Your doctor should make sure that your blood pressure is under control before starting
								Inlyta treatment, and while on treatment with this medicine.</p>
							<ul>
								<li><b>If you have thyroid gland problems.</b></li>
							</ul>
							<p>Inlyta can cause thyroid gland problems. Tell your doctor if you get tired more easily,
								generally feel colder than other people, or your voice deepens whilst taking this
								medicine. Your thyroid function should be checked before you take Inlyta and regularly
								while you are taking it. If your thyroid gland is not producing enough thyroid hormone
								before, or while on treatment with this medicine, you should be treated with thyroid
								hormone replacement.</p>

							<ul>
								<li><b>If you have had a recent problem with blood clots in your veins and arteries
										(types of blood vessels), including stroke, heart attack, embolism, or
										thrombosis.</b></li>
							</ul>
							<p>Get emergency help right away and call your doctor if you get symptoms such as chest pain
								or pressure; pain in your arms, back, neck or jaw; shortness of breath; numbness or
								weakness on one side of your body; trouble talking; headache; vision changes; or
								dizziness while on treatment with this medicine.</p>

							<ul>
								<li><b>If you suffer from bleeding problems.</b></li>
							</ul>
							<p>Inlyta may increase your chance of bleeding. Tell your doctor if you have any bleeding,
								coughing up of blood or bloody sputum while on treatment with this medicine.</p>

							<ul>
								<li><b>If you have or have had an aneurysm (enlargement and weakening of a blood vessel
										wall) or a tear in a blood vessel wall.</b></li>
							</ul>

							<ul>
								<li><b>If during treatment with this medicine you get severe stomach (abdominal) pain or
										stomach pain that does not go away.</b></li>
							</ul>
							<p>Inlyta may increase the risk of developing a hole in the stomach or intestine or
								formation of fistula (abnormal tube-like passage from one normal body cavity to another
								body cavity or the skin).</p>
							<p>Tell your doctor if you have severe abdominal pain while on treatment with this medicine.
							</p>

							<ul>
								<li><b>If you are going to have an operation or if you have an unhealed wound.</b></li>
							</ul>
							<p>Your doctor should stop Inlyta at least 24 hours before your operation as it may affect
								wound healing. Your treatment with this medicine should be restarted when the wound has
								adequately healed.</p>

							<ul>
								<li><b>If during treatment with this medicine, you get symptoms such as headache,
										confusion, seizures (fits), or changes in vision with or without high blood
										pressure.</b></li>
							</ul>
							<p>Get emergency help right away and call your doctor. This could be a rare neurological
								side effect named posterior reversible encephalopathy syndrome.</p>

							<ul>
								<li><b>If you have liver problems.</b></li>
							</ul>
							<p>Your doctor should do blood tests to check your liver function before and during
								treatment with Inlyta.</p>

							<ul>
								<li><b>If during treatment with this medicine, you get symptoms such as excessive
										tiredness, swelling of the abdomen, legs or ankles, shortness of breath, or
										protruding neck veins.</b></li>
							</ul>
							<p>Inlyta may increase the risk of developing heart failure events. Your doctor should
								monitor for signs or symptoms of heart failure events periodically throughout treatment
								with axitinib.</p>

							<p><b>Use in children and adolescents</b></p>
							<p>Inlyta is not recommended for people aged under 18. This medicine has not been studied in
								children and adolescents.</p>
							<p><b>Other medicines and Inlyta</b></p>
							<p>Some medicines may affect Inlyta, or be affected by it. Please tell your doctor,
								pharmacist or nurse about all the medicines you have recently taken, are currently
								taking, or plan to take, including medicines obtained without a prescription, vitamins,
								and herbal medicines. The medicines listed in this leaflet may not be the only ones that
								could interact with Inlyta.</p>

							<p>The following medicines may increase the risk of side effects with Inlyta:</p>
							<ul>
								<li>ketoconazole or itraconazole, used to treat fungal infections;</li>
								<li>clarithromycin, erythromycin or telithromycin, antibiotics used to treat bacterial
									infections;</li>
								<li>atazanavir, indinavir, nelfinavir, ritonavir or saquinavir, used to treat HIV
									infections/AIDS;</li>
								<li>nefazodone, used to treat depression.</li>
							</ul>
							<p>The following medicines may reduce the effectiveness of Inlyta:</p>

							<ul>
								<li>rifampicin, rifabutin or rifapentin, used to treat tuberculosis (TB);</li>
								<li>dexamethasone, a steroid medicine prescribed for many different conditions,
									including serious illnesses;</li>
								<li>phenytoin, carbamazepine or phenobarbital, anti-epileptics used to stop seizures or
									fits;</li>
								<li>St. John’s wort<i> (Hypericum perforatum)</i>, a herbal product used to treat
									depression.</li>

							</ul>
							<p>You <b>should not</b> take these medicines during your treatment with Inlyta. If you are
								taking any of them, tell your doctor, pharmacist or nurse. Your doctor may change the
								dose of these medicines, change the dose of Inlyta, or switch you to a different
								medicine.</p>
							<p>Inlyta may increase side effects associated with theophylline, used to treat asthma or
								other lung diseases.</p>
							<p><b>Inlyta with food and drink</b></p>
							<p>Do not take this medicine with grapefruit or grapefruit juice, as it may increase the
								chance of side effects.</p>

							<p><b>Pregnancy and breast-feeding</b></p>
							<ul>
								<li>If you are pregnant or breast-feeding, think you may be pregnant or are planning to
									have a baby, ask your doctor, pharmacist or nurse for advice before taking this
									medicine.</li>
								<li>Inlyta could harm an unborn baby or breast-fed baby.</li>
								<li>Do not take this medicine during pregnancy. Talk to your doctor before taking it if
									you are pregnant or might become pregnant.</li>
								<li>Use a reliable method of contraception while you are taking Inlyta and up to 1 week
									after the last dose of this medicine, to prevent pregnancy.</li>
								<li>Do not breast-feed during treatment with Inlyta. If you are breast-feeding, your
									doctor should discuss with you whether to discontinue breast-feeding or discontinue
									Inlyta treatment.</li>
							</ul>

							<p><b>Driving and using machines</b></p>
							<p>If you experience dizziness and/or feel tired while on treatment with Inlyta, take
								special care when driving or using machines.</p>

							<p><b>Inlyta contains lactose </b></p>
							<p>If you have been told by your doctor that you have an intolerance to some sugars, contact
								your doctor before taking this medicine.</p>

							<p><b>Inlyta contains sodium</b></p>
							<p>This medicine contains less than 1 mmol (23 mg) sodium per film-coated tablet, that is to
								say essentially ‘sodium-free’.</p>

						</div>
					</text>
				</section>

				<section>
					<title value="3. How to take Inlyta" />
					<text>
						<status value="generated" />
						<div xmlns="http://www.w3.org/1999/xhtml">

							<p>Always take this medicine exactly as your doctor has told you. You should check with your
								doctor, pharmacist or nurse if you are not sure.</p>

							<p>The recommended dose is 5 mg twice a day. Your doctor may subsequently increase or
								decrease your dose depending on how you tolerate treatment with Inlyta.</p>

							<p>Swallow the tablets whole with water, with or without food. Take the Inlyta doses
								approximately 12 hours apart.</p>
							<p><b>If you take more Inlyta than you should</b></p>
							<p>If you accidentally take too many tablets or a higher dose than you need, contact a
								doctor for advice right away. If possible, show the doctor the pack, or this leaflet.
								You may require medical attention.</p>
							<p><b>If you forget to take Inlyta</b></p>
							<p>Take your next dose at your regular time. Do not take a double dose to make up for the
								forgotten tablets.</p>
							<p><b>If you vomit while taking Inlyta</b></p>
							<p>If you vomit, an additional dose should not be taken. The next prescribed dose should be
								taken at the usual time.</p>

							<p><b>If you stop taking Inlyta</b></p>
							<p>If you are not able to take this medicine as your doctor prescribed or you feel you do
								not need it anymore, contact your doctor right away.</p>

							<p>If you have any further questions on the use of this medicine, ask your doctor,
								pharmacist or nurse.</p>

						</div>
					</text>
				</section>

				<section>
					<title value="4. Possible side effects" />
					<text>
						<status value="generated" />
						<div xmlns="http://www.w3.org/1999/xhtml">
							<p>Like all medicines, this medicine can cause side effects, although not everybody gets
								them.</p>
							<p><b>Some side effects could be serious. You must immediately contact your doctor if you
									experience any of those following serious side effects (see also section 2 “What you
									need to know before you take Inlyta”):</b></p>
							<ul>
								<li><b>Heart failure events.</b> Tell your doctor if you experience excessive tiredness,
									swelling of the abdomen, legs, or ankles, shortness of breath, or protruding neck
									veins.</li>
								<li><b>Blood clots in your veins and arteries (types of blood vessels), including
										stroke, heart attack, embolism, or thrombosis.</b> Get emergency help right away
									and call your doctor if you get symptoms such as chest pain or pressure; pain in
									your arms, back, neck or jaw; shortness of breath; numbness or weakness on one side
									of your body; trouble talking; headache; vision changes: or dizziness.</li>
								<li><b>Bleeding.</b> Tell your doctor right away if you have any of these symptoms or a
									serious bleeding problem during treatment with Inlyta: black tarry stools, coughing
									up of blood or bloody sputum, or change in your mental status.</li>
								<li><b>Hole in the stomach or intestine or formation of fistula (abnormal tube-like
										passage from one normal body cavity to another body cavity or the skin).</b>
									Tell your doctor if you have severe abdominal pain.</li>
								<li><b>Severe increase in blood pressure (hypertensive crisis).</b> Tell your doctor if
									you have a very high blood pressure, severe headache, or severe chest pain.</li>
								<li><b>Reversible swelling of the brain (posterior reversible encephalopathy
										syndrome).</b> Get emergency help right away and call your doctor if you get
									symptoms such as headache, confusion, seizures (fits), or changes in vision with or
									without high blood pressure.</li>
							</ul>
							<p>Other side effects with Inlyta may include:</p>

							<p><b>Very common: may affect more than 1 in 10 people</b></p>
							<ul>
								<li>High blood pressure, or increases in blood pressure</li>
								<li>Diarrhoea, feeling or being sick (nausea or vomiting), stomach ache, indigestion,
									soreness of the mouth, tongue or throat, constipation</li>
								<li>Shortness of breath, cough, hoarseness</li>
								<li>Lack of energy, feeling weak or tired</li>
								<li>Under-active thyroid gland (may show in your blood tests)</li>
								<li>Redness and swelling of the palms of the hands or soles of the feet (hand-foot
									syndrome), skin rash, dryness of the skin</li>
								<li>Joint pain, pain in hands or feet</li>
								<li>Loss of appetite</li>
								<li>Protein in the urine (may show in your urine tests)</li>
								<li>Weight loss</li>
								<li>Headache, taste disturbance or loss of taste</li>

							</ul>
							<p><b>Common: may affect up to 1 in 10 people</b></p>
							<ul>
								<li>Dehydration (loss of body fluids)</li>
								<li>Kidney failure</li>
								<li>Flatulence (wind), haemorrhoids, bleeding from gums, bleeding from the rectum, a
									burning or stinging sensation in the mouth</li>
								<li>Hyper-active thyroid gland (may show in your blood tests)</li>
								<li>Sore throat or nose and throat irritation(vomiting)</li>
								<li>Muscle pain</li>
								<li>Nose bleeding</li>
								<li>Skin itching, redness of the skin, hair loss</li>
								<li>Ringing/sound in the ears (tinnitus)</li>
								<li>Reduction in the number of red blood cells (may show in your blood tests)</li>
								<li>Reduction in the number of blood platelets (cells that help blood to clot) (may show
									in your blood tests)</li>
								<li>Presence of red blood cells in the urine (may show in your urine tests)</li>
								<li>Changes in the levels of different chemicals/enzymes in the blood (may show in your
									blood tests)</li>
								<li>Increase in the number of red blood cells (may show in your blood tests)</li>
								<li>Swelling of the abdomen, legs, or ankles, protruding neck veins, excessive
									tiredness, shortness of breath (signs of heart failure events)</li>
								<li>Fistula (abnormal tube like passage from one normal body cavity to another body
									cavity or the skin)</li>
								<li>Dizziness</li>
								<li>Inflammation of the gall bladder</li>

							</ul>
							<p><b>Uncommon: may affect up to 1 in 100 people</b></p>
							<ul>
								<li>Reduction in the number of white blood cells (may show in your blood tests)</li>

							</ul>

							<p><b>Not known: frequency cannot be estimated from the available data</b></p>
							<ul>
								<li>An enlargement and weakening of a blood vessel wall or a tear in a blood vessel wall
									(aneurysms and artery dissections).</li>

							</ul>

							<p><b>Reporting of side effects</b></p>
							<p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any
								possible side effects not listed in this leaflet. By reporting side effects you can help
								provide more information on the safety of this medicine.</p>


						</div>
					</text>
				</section>

				<section>
					<title value="5. How to store Inlyta" />
					<text>
						<status value="generated" />
						<div xmlns="http://www.w3.org/1999/xhtml">
							<p>Keep this medicine out of the sight and reach of children.</p>
							<p>Do not use this medicine after the expiry date which is stated on the carton and on the
								blister foil or bottle after “EXP”. The expiry date refers to the last day of the month.
							</p>
							<p>This medicine should be stored below 30°C.</p>
							<p>Do not use any pack that is damaged or shows signs of tampering.</p>
							<p>Do not throw away any medicines via wastewater or household waste. Ask your
								pharmacist how to throw away medicines you no longer use. These measures will help
								to protect the environment.</p>
						</div>
					</text>
				</section>

				<section>
					<title value="6. Contents of the pack and other information" />
					<text>
						<status value="generated" />
						<div xmlns="http://www.w3.org/1999/xhtml">
							<p>Inlyta 1 mg film-coated tablets are red, oval and debossed with “Pfizer” on one side and
								“1 XNB” on the other. Inlyta 1 mg is available in bottles of 180 tablets and blisters of
								14 tablets. Each blister pack contains 28 tablets or 56 tablets.</p>
							<p><strong>Inlyta 3 mg film-coated tablets</strong></p>
							<p>Inlyta 3 mg film-coated tablets are red, round and debossed with “Pfizer” on one side and
								“3 XNB” on the other. Inlyta 3 mg is available in bottles of 60 tablets and blisters of
								14 tablets. Each blister pack contains 28 tablets or 56 tablets.</p>
							<p><strong>Inlyta 5 mg film-coated tablets</strong></p>
							<p>Inlyta 5 mg film-coated tablets are red, triangular and debossed with “Pfizer” on one
								side and “5 XNB” on the other. Inlyta 5 mg is available in bottles of 60 tablets and
								blisters of 14 tablets. Each blister pack contains 28 tablets or 56 tablets.</p>
							<p><strong>Inlyta 7 mg film-coated tablets</strong></p>
							<p>Inlyta 7 mg film-coated tablets are red, diamond shaped and debossed with “Pfizer” on one
								side and “7 XNB” on the other. Inlyta 7 mg is available in bottles of 60 tablets and
								blisters of 14 tablets. Each blister pack contains 28 tablets or 56 tablets.</p>
							<p>Not all pack sizes may be marketed.</p>

							<p><b>Marketing Authorisation Holder</b></p>
							<p>Pfizer Europe MA EEIG</p>
							<p>Boulevard de la Plaine 17</p>
							<p>1050 Bruxelles</p>
							<p>Belgium</p>
							<p><b>Manufacturer </b></p>
							<p>Pfizer Manufacturing Deutschland GmbH</p>
							<p>Betriebsstätte Freiburg</p>
							<p>Mooswaldallee 1</p>
							<p>79090 Freiburg</p>
							<p>Germany</p>
							<p>For any information about this medicine, please contact the local representative of the
								Marketing
								Authorisation Holder:</p>
							<table border="1">
								<tr>
									<td>
										<p>Belgique/ België /Belgien</p>
										<p>Pfizer SA/NV</p>
										<p>Tél/Tel: +32 (0)2 554 62 11</p>
									</td>
									<td>
										<p>Lietuva</p>
										<p>Pfizer Luxembourg SARL filialas Lietuvoje</p>
										<p>Tel. + 370 52 51 4000</p>
									</td>
								</tr>
								<tr>
									<td>
										<p>България</p>
										<p>Пфайзер Люксембург САРЛ, Клон България</p>
										<p>Тел.: +359 2 970 4333</p>
									</td>
									<td>
										<p>Luxembourg/Luxemburg</p>
										<p>Pfizer S.A.</p>
										<p>Tél/Tel: +32 (0)2 554 62 11</p>
									</td>
								</tr>
								<tr>
									<td>
										<p>Česká republika</p>
										<p>Pfizer, spol. sr.o.</p>
										<p>Tel: +420 283 004 111</p>
									</td>
									<td>
										<p>Magyarország</p>
										<p>Pfizer Kft.</p>
										<p>Tel.: +36-1-488-37-00</p>
									</td>
								</tr>
								<tr>
									<td>
										<p>Danmark</p>
										<p>Pfizer ApS</p>
										<p>Tlf: +45 44 20 11 00</p>
									</td>
									<td>
										<p>Malta</p>
										<p>Vivian Corporation Ltd.</p>
										<p>Tel: +356 21344610</p>
									</td>
								</tr>
								<tr>
									<td>
										<p>Deutschland</p>
										<p>PFIZER PHARMA GmbH</p>
										<p>Tel: +49 (0)30 550055 51000</p>
									</td>
									<td>
										<p>Nederland</p>
										<p>Pfizer BV</p>
										<p>Tel: +31 (0)10 406 43 01</p>
									</td>
								</tr>
								<tr>
									<td>
										<p>Eesti</p>
										<p>Pfizer Luxembourg SARL Eesti filiaal</p>
										<p>Tel.: +372 666 7500</p>
									</td>
									<td>
										<p>Norge</p>
										<p>Pfizer AS</p>
										<p>Tlf: +47 67 52 61 00</p>
									</td>
								</tr>
								<tr>
									<td>
										<p>Ελλάδα</p>
										<p>Pfizer Ελλάς A.E.</p>
										<p>Τλ: +30 210 6785 800</p>
									</td>
									<td>
										<p>Österreich</p>
										<p>Pfizer Corporation Austria Ges.m.b.H.</p>
										<p>Tel: +43 (0)1 521 15-0</p>
									</td>
								</tr>
								<tr>
									<td>
										<p>España</p>
										<p>Pfizer S.L.</p>
										<p>Tél: +34 91 490 99 00</p>
									</td>
									<td>
										<p>Polska</p>
										<p>Pfizer Polska Sp. z o.o.</p>
										<p>Tel.:+48 22 335 61 00</p>
									</td>
								</tr>
								<tr>
									<td>
										<p>France</p>
										<p>Pfizer</p>
										<p>Tél: +33 (0)1 58 07 34 40</p>
									</td>
									<td>
										<p>Portugal</p>
										<p>Laboratórios Pfizer, Lda.</p>
										<p>Tel: +351 21 423 5500</p>
									</td>
								</tr>
								<tr>
									<td>
										<p>Hrvatska</p>
										<p>Pfizer Croatia d.o.o.</p>
										<p>Tel: + 385 1 3908 777</p>
									</td>
									<td>
										<p>România</p>
										<p>Pfizer Romania S.R.L.</p>
										<p>Tel: +40 (0) 21 207 28 00</p>
									</td>
								</tr>
								<tr>
									<td>
										<p>Ísland</p>
										<p>Icepharma hf.</p>
										<p>Sími: +354 540 8000</p>
									</td>
									<td>
										<p>Slovenská republika</p>
										<p>Pfizer Luxembourg SARL, organizačná zložka</p>
										<p>Tel.: + 421 2 3355 5500</p>
									</td>
								</tr>
								<tr>
									<td>
										<p>Ireland</p>
										<p>Pfizer Healthcare Ireland</p>
										<p>Tel: 1800 633 363 (toll free)<br />+44 (0)1304 616161</p>
									</td>
									<td>
										<p>Slovenija</p>
										<p>Pfizer Luxembourg SARL<br />Pfizer, podružnica za svetovanje s področja
											farmacevtske dejavnosti,
											Ljubljana</p>
										<p>Tel.: + 386 (0)1 52 11 400</p>
									</td>
								</tr>
								<tr>
									<td>
										<p>Italia</p>
										<p>Pfizer S.r.l.</p>
										<p>Tel: +39 06 33 18 21</p>
									</td>
									<td>
										<p>Suomi/Finland</p>
										<p>Pfizer Oy</p>
										<p>Puh./Tel: +358 (0)9 43 00 40</p>
									</td>
								</tr>
								<tr>
									<td>
										<p>Kύπρος</p>
										<p>Pfizer Ελλάς Α.Ε. (Cyprus Branch)</p>
										<p>Τηλ: +357 22 817690</p>
									</td>
									<td>
										<p>Sverige</p>
										<p>Pfizer AB</p>
										<p>Tel: +46 (0)8 550 520 00</p>
									</td>
								</tr>
								<tr>
									<td>
										<p>Latvija</p>
										<p>Pfizer Luxembourg SARL filiāle Latvijā</p>
										<p>Tel.: + 371 670 35 775</p>
									</td>
									<td>
										<p>United Kingdom (Northern Ireland)</p>
										<p>Pfizer Limited</p>
										<p>Tel: +44 (0) 1304 616161</p>
									</td>
								</tr>
							</table>
							<p><strong>This leaflet was last revised in</strong></p>
							<p><strong>Other sources of information</strong></p>
							<p>Detailed information on this medicine is available on the European Medicines Agency web
								site:<br />
								<a href="http://www.ema.europa.eu/">http://www.ema.europa.eu/</a>
							</p>
						</div>
					</text>
				</section>
			</Composition>
		</resource>
	</entry>
	<entry>
		<fullUrl value="Organization/PfizerEuropeMAEEIG" />
		<resource>
			<Organization>
				<id value="PfizerEuropeMAEEIG" />
				<meta>
				<profile
					value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi" />
				</meta>
				<identifier>
					<use value="official" />
					<system value="https://spor.ema.europa.eu/omswi" />
					<value value="ORG-100011459" />
				</identifier>
				<active value="true" />
				<type>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi" />
						<code value="220000000034" />
						<display value="Marketing authorisation holder" />
					</coding>
					<text value="Marketing authorisation holder" />
				</type>
				<name value="Pfizer Europe MA EEIG" />
				<contact>
					<address>
						<use value="work" />
						<type value="physical" />
						<text value="Pfizer Europe MA EEIG
                        Boulevard de la Plaine 17
                        1050 Bruxelles
                        Belgium" />
						<line value="Boulevard de la Plaine 17" />
						<city value="Bruxelles" />
						<country value="BE" />
					</address>
				</contact>
			</Organization>
		</resource>
	</entry>
	<entry>
		<fullUrl value="Organization/pfizergermany" />
		<resource>
			<Organization>
				<id value="pfizergermany" />
				<meta>
				<profile
					value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi" />
				</meta>
				<identifier>
					<use value="official" />
					<system value="https://leaflet.healthcare/sid/organization" />
					<value value="ORG-100004089" />
				</identifier>
				<active value="true" />
				<type>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi" />
						<code value="220000000033" />
						<display value="Manufacturer" />
					</coding>
				</type>
				<name value="Pfizer Europe MA EEIG" />
				<contact>
					<address>
						<use value="work" />
						<type value="physical" />
						<text value="Pfizer Manufacturing Deutschland GmbH
						Betriebsstätte Freiburg
						Mooswaldallee 1
						79090 Freiburg
						Germany" />
						<line value="Mooswaldallee 1" />
						<city value="Freiburg" />
						<postalCode value="79090" />
						<country value="Germany" />
					</address>
				</contact>
			</Organization>
		</resource>
	</entry>

	<entry>
		<fullUrl value="Ingredient/axitinib1" />
		<resource>
			<Ingredient>
				<id value="axitinib1" />
				<identifier>
					<use value="official" />
					<system value="http://fdasis.nlm.nih.gov" />
					<value value="C9LVQ0YUXG" />
				</identifier>
				<status value="active" />
				<for>
					<reference value="ManufacturedItemDefinition/inlyta1mg" />
				</for>
				<role>
					<coding>
						<system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
						<code value="ACTIB" />
						<display value="active ingredient - basis of strength" />
					</coding>
				</role>
				<allergenicIndicator value="false" />
				<substance>
					<code>
							<reference>
								<reference value="SubstanceDefinition/axitinib" />
							</reference>
						</code>
					<strength>
						<presentationQuantity>
							<system value="http://unitsofmeasure.org" />
							<value value="1" />
							<unit value="mg" />
							<code value="mg" />
						</presentationQuantity>
					</strength>
				</substance>
			</Ingredient>
		</resource>
	</entry>

	<entry>
		<fullUrl value="Ingredient/axitinib3" />
		<resource>
			<Ingredient>
				<id value="axitinib3" />
				<identifier>
					<use value="official" />
					<system value="http://fdasis.nlm.nih.gov" />
					<value value="C9LVQ0YUXG" />
				</identifier>
				<status value="active" />
				<for>
					<reference value="ManufacturedItemDefinition/inlyta3mg" />
				</for>
				<role>
					<coding>
						<system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
						<code value="ACTIB" />
						<display value="active ingredient - basis of strength" />
					</coding>
				</role>
				<allergenicIndicator value="false" />
				<substance>
					<code>
							<reference>
								<reference value="SubstanceDefinition/axitinib" />
							</reference>
						</code>
					<strength>
						<presentationQuantity>
							<system value="http://unitsofmeasure.org" />
							<value value="3" />
							<unit value="mg" />
							<code value="mg" />
						</presentationQuantity>
					</strength>
				</substance>
			</Ingredient>
		</resource>
	</entry>

	<entry>
		<fullUrl value="Ingredient/axitinib5" />
		<resource>
			<Ingredient>
				<id value="axitinib5" />
				<identifier>
					<use value="official" />
					<system value="http://fdasis.nlm.nih.gov" />
					<value value="C9LVQ0YUXG" />
				</identifier>
				<status value="active" />
				<for>
					<reference value="ManufacturedItemDefinition/inlyta5mg" />
				</for>
				<role>
					<coding>
						<system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
						<code value="ACTIB" />
						<display value="active ingredient - basis of strength" />
					</coding>
				</role>
				<allergenicIndicator value="false" />
				<substance>
					<code>
							<reference>
								<reference value="SubstanceDefinition/axitinib" />
							</reference>
						</code>
					<strength>
						<presentationQuantity>
							<system value="http://unitsofmeasure.org" />
							<value value="5" />
							<unit value="mg" />
							<code value="mg" />
						</presentationQuantity>
					</strength>
				</substance>
			</Ingredient>
		</resource>
	</entry>

	<entry>
		<fullUrl value="Ingredient/axitinib7" />
		<resource>
			<Ingredient>
				<id value="axitinib7" />
				<identifier>
					<use value="official" />
					<system value="http://fdasis.nlm.nih.gov" />
					<value value="C9LVQ0YUXG" />
				</identifier>
				<status value="active" />
				<for>
					<reference value="ManufacturedItemDefinition/inlyta7mg" />
				</for>
				<role>
					<coding>
						<system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
						<code value="ACTIB" />
						<display value="active ingredient - basis of strength" />
					</coding>
				</role>
				<allergenicIndicator value="false" />
				<substance>
					<code>
							<reference>
								<reference value="SubstanceDefinition/axitinib" />
							</reference>
						</code>
					<strength>
						<presentationQuantity>
							<system value="http://unitsofmeasure.org" />
							<value value="7" />
							<unit value="mg" />
							<code value="mg" />
						</presentationQuantity>
					</strength>
				</substance>
			</Ingredient>
		</resource>
	</entry>

	<entry>
		<fullUrl value="Ingredient/MICROCRYSTALLINECELLULOSE" />
		<resource>
			<Ingredient>
				<id value="MICROCRYSTALLINECELLULOSE" />
				<meta>
					<profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi" />
				</meta>
				<identifier>
					<use value="official" />
					<system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
					<value value="OP1R32D61U" />
				</identifier>
				<status value="active" />
				<for>
					<reference value="ManufacturedItemDefinition/inlyta1mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta3mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta5mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta7mg" />
				</for>
				<role>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi" />
						<code value="100000072082" />
						<display value="Excipient" />
					</coding>
				</role>
				<allergenicIndicator value="false" />
				<substance>
					<code>
						<concept>
							<coding>
								<system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
								<code value="OP1R32D61U" />
								<display value="MICROCRYSTALLINE CELLULOSE" />
							</coding>
						</concept>
					</code>
				</substance>
			</Ingredient>
		</resource>
	</entry>

	<entry>
		<fullUrl value="Ingredient/LACTOSEMONOHYDRATE" />
		<resource>
			<Ingredient>
				<id value="LACTOSEMONOHYDRATE" />
				<meta>
					<profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi" />
				</meta>
				<identifier>
					<use value="official" />
					<system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
					<value value="EWQ57Q8I5X" />
				</identifier>
				<status value="active" />
				<for>
					<reference value="ManufacturedItemDefinition/inlyta1mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta3mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta5mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta7mg" />
				</for>
				<role>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi" />
						<code value="100000072082" />
						<display value="Excipient" />
					</coding>
				</role>
				<allergenicIndicator value="false" />
				<substance>
					<code>
						<concept>
							<coding>
								<system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
								<code value="EWQ57Q8I5X" />
								<display value="LACTOSE MONOHYDRATE" />
							</coding>
						</concept>
					</code>
				</substance>
			</Ingredient>
		</resource>
	</entry>

	<entry>
		<fullUrl value="Ingredient/CROSCARMELLOSESODIUM" />
		<resource>
			<Ingredient>
				<id value="CROSCARMELLOSESODIUM" />
				<meta>
					<profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi" />
				</meta>
				<identifier>
					<use value="official" />
					<system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
					<value value="M28OL1HH48" />
				</identifier>
				<status value="active" />
				<for>
					<reference value="ManufacturedItemDefinition/inlyta1mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta3mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta5mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta7mg" />
				</for>
				<role>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi" />
						<code value="100000072082" />
						<display value="Excipient" />
					</coding>
				</role>
				<allergenicIndicator value="false" />
				<substance>
					<code>
						<concept>
							<coding>
								<system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
								<code value="M28OL1HH48" />
								<display value="CROSCARMELLOSE SODIUM" />
							</coding>
						</concept>
					</code>
				</substance>
			</Ingredient>
		</resource>
	</entry>

	<entry>
		<fullUrl value="Ingredient/MAGNESIUMSTEARATE" />
		<resource>
			<Ingredient>
				<id value="MAGNESIUMSTEARATE" />
				<meta>
					<profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi" />
				</meta>
				<identifier>
					<use value="official" />
					<system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
					<value value="70097M6I30" />
				</identifier>
				<status value="active" />
				<for>
					<reference value="ManufacturedItemDefinition/inlyta1mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta3mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta5mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta7mg" />
				</for>
				<role>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi" />
						<code value="100000072082" />
						<display value="Excipient" />
					</coding>
				</role>
				<allergenicIndicator value="false" />
				<substance>
					<code>
						<concept>
							<coding>
								<system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
								<code value="70097M6I30" />
								<display value="MAGNESIUM STEARATE" />
							</coding>
						</concept>
					</code>
				</substance>
			</Ingredient>
		</resource>
	</entry>

	<entry>
		<fullUrl value="Ingredient/HYPROMELLOSE2910" />
		<resource>
			<Ingredient>
				<id value="HYPROMELLOSE2910" />
				<meta>
					<profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi" />
				</meta>
				<identifier>
					<use value="official" />
					<system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
					<value value="36SFW2JZ0W" />
				</identifier>
				<status value="active" />
				<for>
					<reference value="ManufacturedItemDefinition/inlyta1mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta3mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta5mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta7mg" />
				</for>
				<role>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi" />
						<code value="100000072082" />
						<display value="Excipient" />
					</coding>
				</role>
				<allergenicIndicator value="false" />
				<substance>
					<code>
						<concept>
							<coding>
								<system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
								<code value="36SFW2JZ0W" />
								<display value="HYPROMELLOSE 2910 (15 mPa·s)" />
							</coding>
						</concept>
					</code>
				</substance>
			</Ingredient>
		</resource>
	</entry>

	<entry>
		<fullUrl value="Ingredient/TITANIUMDIOXIDE" />
		<resource>
			<Ingredient>
				<id value="TITANIUMDIOXIDE" />
				<meta>
					<profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi" />
				</meta>
				<identifier>
					<use value="official" />
					<system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
					<value value="15FIX9V2JP" />
				</identifier>
				<status value="active" />
				<for>
					<reference value="ManufacturedItemDefinition/inlyta1mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta3mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta5mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta7mg" />
				</for>
				<role>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi" />
						<code value="100000072082" />
						<display value="Excipient" />
					</coding>
				</role>
				<allergenicIndicator value="false" />
				<substance>
					<code>
						<concept>
							<coding>
								<system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
								<code value="15FIX9V2JP" />
								<display value="TITANIUM DIOXIDE" />
							</coding>
						</concept>
					</code>
				</substance>
			</Ingredient>
		</resource>
	</entry>

	<entry>
		<fullUrl value="Ingredient/TRIACETIN" />
		<resource>
			<Ingredient>
				<id value="TRIACETIN" />
				<meta>
					<profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi" />
				</meta>
				<identifier>
					<use value="official" />
					<system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
					<value value="XHX3C3X673" />
				</identifier>
				<status value="active" />
				<for>
					<reference value="ManufacturedItemDefinition/inlyta1mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta3mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta5mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta7mg" />
				</for>
				<role>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi" />
						<code value="100000072082" />
						<display value="Excipient" />
					</coding>
				</role>
				<allergenicIndicator value="false" />
				<substance>
					<code>
						<concept>
							<coding>
								<system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
								<code value="XHX3C3X673" />
								<display value="TRIACETIN" />
							</coding>
						</concept>
					</code>
				</substance>
			</Ingredient>
		</resource>
	</entry>

	<entry>
		<fullUrl value="Ingredient/IRONOXIDERED" />
		<resource>
			<Ingredient>
				<id value="IRONOXIDERED" />
				<meta>
					<profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi" />
				</meta>
				<identifier>
					<use value="official" />
					<system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
					<value value="1K09F3G675" />
				</identifier>
				<status value="active" />
				<for>
					<reference value="ManufacturedItemDefinition/inlyta1mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta3mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta5mg" />
				</for>
				<for>
					<reference value="ManufacturedItemDefinition/inlyta7mg" />
				</for>
				<role>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi" />
						<code value="100000072082" />
						<display value="Excipient" />
					</coding>
				</role>
				<allergenicIndicator value="false" />
				<substance>
					<code>
						<concept>
							<coding>
								<system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
								<code value="1K09F3G675" />
								<display value="IRON OXIDE RED" />
							</coding>
						</concept>
					</code>
				</substance>
			</Ingredient>
		</resource>
	</entry>

	<entry>
		<fullUrl value="SubstanceDefinition/axitinib" />
		<resource>
			<SubstanceDefinition>
				<id value="axitinib" />
				<meta>
					<profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi" />
				</meta>
				<identifier>
					<use value="official" />
					<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/" />
					<value value="C9LVQ0YUXG" />
				</identifier>
				<version value="1" />
				<status>
					<coding>
						<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/" />
						<code value="1" />
						<display value="Validated (UNII)" />
					</coding>
				</status>
				<molecularWeight>
					<type>
						<text value="exact" />
					</type>
					<amount>
						<value value="386.47" />
					</amount>
				</molecularWeight>
				<structure>
					<molecularFormula value="C22H18N4OS" />
				</structure>
				<name>
					<name value="Axitinib" />
					<type>
						<coding>
							<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/" />
							<code value="x" />
							<display value="Chemical Name" />
						</coding>
					</type>
				</name>
			</SubstanceDefinition>
		</resource>
	</entry>

	<entry>
		<fullUrl value="ManufacturedItemDefinition/inlyta1mg" />
		<resource>
			<ManufacturedItemDefinition>
				<id value="inlyta1mg" />
				<meta>
					<profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi" />
				</meta>
				<identifier>
					<use value="official" />
					<system value="http://ema.europa.eu/fhir/epiDocument" />
					<value value="inlyta-1mg-identifier" />
				</identifier>
				<status value="active" />
				<manufacturedDoseForm>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi/" />
						<code value="100000073646" />
						<display value="Film-coated tablet" />
					</coding>
				</manufacturedDoseForm>
				<unitOfPresentation>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi" />
						<code value="200000002120" />
						<display value="Tablet" />
					</coding>
				</unitOfPresentation>
				<manufacturer>
					<reference value="Organization/pfizergermany" />
				</manufacturer>
			</ManufacturedItemDefinition>
		</resource>
	</entry>

	<entry>
		<fullUrl value="ManufacturedItemDefinition/inlyta3mg" />
		<resource>
			<ManufacturedItemDefinition>
				<id value="inlyta3mg" />
				<meta>
					<profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi" />
				</meta>
				<identifier>
					<use value="official" />
					<system value="http://ema.europa.eu/fhir/epiDocument" />
					<value value="inlyta-3mg-identifier" />
				</identifier>
				<status value="active" />
				<manufacturedDoseForm>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi/" />
						<code value="100000073646" />
						<display value="Film-coated tablet" />
					</coding>
				</manufacturedDoseForm>
				<unitOfPresentation>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi" />
						<code value="200000002120" />
						<display value="Tablet" />
					</coding>
				</unitOfPresentation>
				<manufacturer>
					<reference value="Organization/pfizergermany" />
				</manufacturer>
			</ManufacturedItemDefinition>
		</resource>
	</entry>

	<entry>
		<fullUrl value="ManufacturedItemDefinition/inlyta5mg" />
		<resource>
			<ManufacturedItemDefinition>
				<id value="inlyta5mg" />
				<meta>
					<profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi" />
				</meta>
				<identifier>
					<use value="official" />
					<system value="http://ema.europa.eu/fhir/epiDocument" />
					<value value="inlyta-5mg-identifier" />
				</identifier>
				<status value="active" />
				<manufacturedDoseForm>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi/" />
						<code value="100000073646" />
						<display value="Film-coated tablet" />
					</coding>
				</manufacturedDoseForm>
				<unitOfPresentation>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi" />
						<code value="200000002120" />
						<display value="Tablet" />
					</coding>
				</unitOfPresentation>
				<manufacturer>
					<reference value="Organization/pfizergermany" />
				</manufacturer>
			</ManufacturedItemDefinition>
		</resource>
	</entry>

	<entry>
		<fullUrl value="ManufacturedItemDefinition/inlyta7mg" />
		<resource>
			<ManufacturedItemDefinition>
				<id value="inlyta7mg" />
				<meta>
					<profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi" />
				</meta>
				<identifier>
					<use value="official" />
					<system value="http://ema.europa.eu/fhir/epiDocument" />
					<value value="inlyta-7mg-identifier" />
				</identifier>
				<status value="active" />
				<manufacturedDoseForm>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi/" />
						<code value="100000073646" />
						<display value="Film-coated tablet" />
					</coding>
				</manufacturedDoseForm>
				<unitOfPresentation>
					<coding>
						<system value="https://spor.ema.europa.eu/rmswi" />
						<code value="200000002120" />
						<display value="Tablet" />
					</coding>
				</unitOfPresentation>
				<manufacturer>
					<reference value="Organization/pfizergermany" />
				</manufacturer>
			</ManufacturedItemDefinition>
		</resource>
	</entry>
	<entry>
        <fullUrl value="PackagedProductDefinition/inlyta-1mg-bottle" />
        <resource>
            <PackagedProductDefinition>
                <id value="inlyta-1mg-bottle" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://spor.ema.europa.eu/pmswi" />
                    <value value="b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab" />
                </identifier>
                <name value="Bottle of 180 tablets" />
                <type>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000155527" />
                        <display value="Chemical Medicinal Product" />
                    </coding>
                </type>
                <packageFor>
                    <reference value="MedicinalProductDefinition/inlyta-1mg" />
                </packageFor>
                <status>
                    <coding>
                        <system value="http://hl7.org/fhir/publication-status" />
                        <code value="active" />
                        <display value="Active" />
                    </coding>
                </status>
                <statusDate value="2023-02-17T00:00:00Z" />
                <containedItemQuantity>
                    <value value="1" />
                    <system value="http://unitsofmeasure.org" />
                    <code value="1" />
                </containedItemQuantity>
                <description value="Inlyta 1 mg film-coated tablets are red, oval and debossed with “Pfizer” on one side and “1 XNB” on 
				the other. Inlyta 1 mg is available in bottles of 180 tablets and blisters of 14 tablets. Each blister pack
				contains 28 tablets or 56 tablets." />
                <manufacturer>
                    <reference value="Organization/pfizergermany" />
                </manufacturer>
                <packaging>
                    <identifier>
                        <system value="https://spor.ema.europa.eu/pmswi" />
                        <value value="5913fadd-6172-4282-ad02-19ab9d063b66" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/rmswi" />
                            <code value="100000073497" />
                            <display value="Bottle" />
                        </coding>
                    </type>
                    <quantity value="1" />
                    <material>
                        <coding>
                            <system value="https://spor.ema.europa.eu/rmswi" />
                            <code value="200000003215" />
                            <display value="High Density PolyEthylene" />
                        </coding>
                    </material>
                    <containedItem>
                        <item>
                            <reference>
                                <reference value="ManufacturedItemDefinition/inlyta1mg" />
                            </reference>
                        </item>
                        <amount>
                            <value value="1" />
                            <unit value="mm" />
                            <system value="http://unitsofmeasure.org" />
                            <code value="mg" />
                        </amount>
                    </containedItem>
                </packaging>
            </PackagedProductDefinition>
        </resource>
    </entry>

<entry>
    <fullUrl value="PackagedProductDefinition/inlyta-3mg-bottle" />
    <resource>
        <PackagedProductDefinition>
            <id value="inlyta-3mg-bottle" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi" />
            </meta>
            <identifier>
                <use value="official" />
                <system value="https://spor.ema.europa.eu/pmswi" />
                <value value="b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab" />
            </identifier>
            <name value="Bottle of 60 tablets" />
            <type>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="100000155527" />
                    <display value="Chemical Medicinal Product" />
                </coding>
            </type>
            <packageFor>
                <reference value="MedicinalProductDefinition/inlyta-3mg" />
            </packageFor>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="Active" />
                </coding>
            </status>
            <statusDate value="2023-02-17T00:00:00Z" />
            <containedItemQuantity>
                <value value="1" />
                <system value="http://unitsofmeasure.org" />
                <code value="1" />
            </containedItemQuantity>
            <description value="Inlyta 3 mg film-coated tablets are red, oval and debossed with “Pfizer” on one side and “3 XNB” on the other. Inlyta 3 mg is available in bottles of 60 tablets." />
            <manufacturer>
                <reference value="Organization/pfizergermany" />
            </manufacturer>
            <packaging>
                <identifier>
                    <system value="https://spor.ema.europa.eu/pmswi" />
                    <value value="5913fadd-6172-4282-ad02-19ab9d063b66" />
                </identifier>
                <type>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000073497" />
                        <display value="Bottle" />
                    </coding>
                </type>
                <quantity value="1" />
                <material>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="200000003215" />
                        <display value="High Density PolyEthylene" />
                    </coding>
                </material>
                <containedItem>
                    <item>
                        <reference>
                            <reference value="ManufacturedItemDefinition/inlyta3mg" />
                        </reference>
                    </item>
                    <amount>
                        <value value="3" />
                        <unit value="mm" />
                        <system value="http://unitsofmeasure.org" />
                        <code value="mg" />
                    </amount>
                </containedItem>
            </packaging>
        </PackagedProductDefinition>
    </resource>
</entry>

<entry>
    <fullUrl value="PackagedProductDefinition/inlyta-5mg-bottle" />
    <resource>
        <PackagedProductDefinition>
            <id value="inlyta-5mg-bottle" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi" />
            </meta>
            <identifier>
                <use value="official" />
                <system value="https://spor.ema.europa.eu/pmswi" />
                <value value="b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab" />
            </identifier>
            <name value="Bottle of 60 tablets" />
            <type>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="100000155527" />
                    <display value="Chemical Medicinal Product" />
                </coding>
            </type>
            <packageFor>
                <reference value="MedicinalProductDefinition/inlyta-5mg" />
            </packageFor>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="Active" />
                </coding>
            </status>
            <statusDate value="2023-02-17T00:00:00Z" />
            <containedItemQuantity>
                <value value="1" />
                <system value="http://unitsofmeasure.org" />
                <code value="1" />
            </containedItemQuantity>
            <description value="Inlyta 5 mg film-coated tablets are red, oval and debossed with “Pfizer” on one side and “5 XNB” on the other. Inlyta 5 mg is available in bottles of 60 tablets." />
            <manufacturer>
                <reference value="Organization/pfizergermany" />
            </manufacturer>
            <packaging>
                <identifier>
                    <system value="https://spor.ema.europa.eu/pmswi" />
                    <value value="5913fadd-6172-4282-ad02-19ab9d063b66" />
                </identifier>
                <type>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000073497" />
                        <display value="Bottle" />
                    </coding>
                </type>
                <quantity value="1" />
                <material>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="200000003215" />
                        <display value="High Density PolyEthylene" />
                    </coding>
                </material>
                <containedItem>
                    <item>
                        <reference>
                            <reference value="ManufacturedItemDefinition/inlyta5mg" />
                        </reference>
                    </item>
                    <amount>
                        <value value="5" />
                        <unit value="mm" />
                        <system value="http://unitsofmeasure.org" />
                        <code value="mg" />
                    </amount>
                </containedItem>
            </packaging>
        </PackagedProductDefinition>
    </resource>
</entry>

<entry>
    <fullUrl value="PackagedProductDefinition/inlyta-7mg-bottle" />
    <resource>
        <PackagedProductDefinition>
            <id value="inlyta-7mg-bottle" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi" />
            </meta>
            <identifier>
                <use value="official" />
                <system value="https://spor.ema.europa.eu/pmswi" />
                <value value="b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab" />
            </identifier>
            <name value="Bottle of 60 tablets" />
            <type>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="100000155527" />
                    <display value="Chemical Medicinal Product" />
                </coding>
            </type>
            <packageFor>
                <reference value="MedicinalProductDefinition/inlyta-7mg" />
            </packageFor>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="Active" />
                </coding>
            </status>
            <statusDate value="2023-02-17T00:00:00Z" />
            <containedItemQuantity>
                <value value="1" />
                <system value="http://unitsofmeasure.org" />
                <code value="1" />
            </containedItemQuantity>
            <description value="Inlyta 7 mg film-coated tablets are red, oval and debossed with “Pfizer” on one side and “7 XNB” on the other. Inlyta 7 mg is available in bottles of 60 tablets." />
            <manufacturer>
                <reference value="Organization/pfizergermany" />
            </manufacturer>
            <packaging>
                <identifier>
                    <system value="https://spor.ema.europa.eu/pmswi" />
                    <value value="5913fadd-6172-4282-ad02-19ab9d063b66" />
                </identifier>
                <type>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000073497" />
                        <display value="Bottle" />
                    </coding>
                </type>
                <quantity value="1" />
                <material>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="200000003215" />
                        <display value="High Density PolyEthylene" />
                    </coding>
                </material>
                <containedItem>
                    <item>
                        <reference>
                            <reference value="ManufacturedItemDefinition/inlyta7mg" />
                        </reference>
                    </item>
                    <amount>
                        <value value="7" />
                        <unit value="mm" />
                        <system value="http://unitsofmeasure.org" />
                        <code value="mg" />
                    </amount>
                </containedItem>
            </packaging>
        </PackagedProductDefinition>
    </resource>
</entry>

<entry>
    <fullUrl value="PackagedProductDefinition/inlyta-1mg-blister-28" />
    <resource>
        <PackagedProductDefinition>
            <id value="inlyta-1mg-blister-28" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi" />
            </meta>
            <identifier>
                <use value="official" />
                <system value="https://spor.ema.europa.eu/pmswi" />
                <value value="b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab" />
            </identifier>
            <name value="Blister of 28 tablets" />
            <type>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="100000155527" />
                    <display value="Chemical Medicinal Product" />
                </coding>
            </type>
            <packageFor>
                <reference value="MedicinalProductDefinition/inlyta-1mg" />
            </packageFor>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="Active" />
                </coding>
            </status>
            <statusDate value="2023-02-17T00:00:00Z" />
            <containedItemQuantity>
                <value value="1" />
                <system value="http://unitsofmeasure.org" />
                <code value="1" />
            </containedItemQuantity>
            <description value="Inlyta 1 mg film-coated tablets are red, oval and debossed with “Pfizer” on one side and “1 XNB” on the other. Inlyta 1 mg is available in blisters of 28 tablets." />
            <manufacturer>
                <reference value="Organization/pfizergermany" />
            </manufacturer>
            <packaging>
                <identifier>
                    <system value="https://spor.ema.europa.eu/pmswi" />
                    <value value="5913fadd-6172-4282-ad02-19ab9d063b66" />
                </identifier>
                <type>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000073497" />
                        <display value="Blister" />
                    </coding>
                </type>
                <quantity value="1" />
                <material>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="200000003215" />
                        <display value="High Density PolyEthylene" />
                    </coding>
                </material>
                <containedItem>
                    <item>
                        <reference>
                            <reference value="ManufacturedItemDefinition/inlyta1mg" />
                        </reference>
                    </item>
                    <amount>
                        <value value="1" />
                        <unit value="mm" />
                        <system value="http://unitsofmeasure.org" />
                        <code value="mg" />
                    </amount>
                </containedItem>
            </packaging>
        </PackagedProductDefinition>
    </resource>
</entry>

<entry>
    <fullUrl value="PackagedProductDefinition/inlyta-1mg-blister-56" />
    <resource>
        <PackagedProductDefinition>
            <id value="inlyta-1mg-blister-56" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi" />
            </meta>
            <identifier>
                <use value="official" />
                <system value="https://spor.ema.europa.eu/pmswi" />
                <value value="b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab" />
            </identifier>
            <name value="Blister of 56 tablets" />
            <type>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="100000155527" />
                    <display value="Chemical Medicinal Product" />
                </coding>
            </type>
            <packageFor>
                <reference value="MedicinalProductDefinition/inlyta-1mg" />
            </packageFor>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="Active" />
                </coding>
            </status>
            <statusDate value="2023-02-17T00:00:00Z" />
            <containedItemQuantity>
                <value value="1" />
                <system value="http://unitsofmeasure.org" />
                <code value="1" />
            </containedItemQuantity>
            <description value="Inlyta 1 mg film-coated tablets are red, oval and debossed with “Pfizer” on one side and “1 XNB” on the other. Inlyta 1 mg is available in blisters of 56 tablets." />
            <manufacturer>
                <reference value="Organization/pfizergermany" />
            </manufacturer>
            <packaging>
                <identifier>
                    <system value="https://spor.ema.europa.eu/pmswi" />
                    <value value="5913fadd-6172-4282-ad02-19ab9d063b66" />
                </identifier>
                <type>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000073497" />
                        <display value="Blister" />
                    </coding>
                </type>
                <quantity value="1" />
                <material>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="200000003215" />
                        <display value="High Density PolyEthylene" />
                    </coding>
                </material>
                <containedItem>
                    <item>
                        <reference>
                            <reference value="ManufacturedItemDefinition/inlyta1mg" />
                        </reference>
                    </item>
                    <amount>
                        <value value="1" />
                        <unit value="mm" />
                        <system value="http://unitsofmeasure.org" />
                        <code value="mg" />
                    </amount>
                </containedItem>
            </packaging>
        </PackagedProductDefinition>
    </resource>
</entry>

<entry>
    <fullUrl value="PackagedProductDefinition/inlyta-3mg-blister-28" />
    <resource>
        <PackagedProductDefinition>
            <id value="inlyta-3mg-blister-28" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi" />
            </meta>
            <identifier>
                <use value="official" />
                <system value="https://spor.ema.europa.eu/pmswi" />
                <value value="b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab" />
            </identifier>
            <name value="Blister of 28 tablets" />
            <type>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="100000155527" />
                    <display value="Chemical Medicinal Product" />
                </coding>
            </type>
            <packageFor>
                <reference value="MedicinalProductDefinition/inlyta-3mg" />
            </packageFor>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="Active" />
                </coding>
            </status>
            <statusDate value="2023-02-17T00:00:00Z" />
            <containedItemQuantity>
                <value value="1" />
                <system value="http://unitsofmeasure.org" />
                <code value="1" />
            </containedItemQuantity>
            <description value="Inlyta 3 mg film-coated tablets are red, oval and debossed with “Pfizer” on one side and “3 XNB” on the other. Inlyta 3 mg is available in blisters of 28 tablets." />
            <manufacturer>
                <reference value="Organization/pfizergermany" />
            </manufacturer>
            <packaging>
                <identifier>
                    <system value="https://spor.ema.europa.eu/pmswi" />
                    <value value="5913fadd-6172-4282-ad02-19ab9d063b66" />
                </identifier>
                <type>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000073497" />
                        <display value="Blister" />
                    </coding>
                </type>
                <quantity value="1" />
                <material>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="200000003215" />
                        <display value="High Density PolyEthylene" />
                    </coding>
                </material>
                <containedItem>
                    <item>
                        <reference>
                            <reference value="ManufacturedItemDefinition/inlyta3mg" />
                        </reference>
                    </item>
                    <amount>
                        <value value="1" />
                        <unit value="mm" />
                        <system value="http://unitsofmeasure.org" />
                        <code value="mg" />
                    </amount>
                </containedItem>
            </packaging>
        </PackagedProductDefinition>
    </resource>
</entry>

<entry>
    <fullUrl value="PackagedProductDefinition/inlyta-3mg-blister-56" />
    <resource>
        <PackagedProductDefinition>
            <id value="inlyta-3mg-blister-56" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi" />
            </meta>
            <identifier>
                <use value="official" />
                <system value="https://spor.ema.europa.eu/pmswi" />
                <value value="b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab" />
            </identifier>
            <name value="Blister of 56 tablets" />
            <type>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="100000155527" />
                    <display value="Chemical Medicinal Product" />
                </coding>
            </type>
            <packageFor>
                <reference value="MedicinalProductDefinition/inlyta-3mg" />
            </packageFor>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="Active" />
                </coding>
            </status>
            <statusDate value="2023-02-17T00:00:00Z" />
            <containedItemQuantity>
                <value value="1" />
                <system value="http://unitsofmeasure.org" />
                <code value="1" />
            </containedItemQuantity>
            <description value="Inlyta 3 mg film-coated tablets are red, oval and debossed with “Pfizer” on one side and “3 XNB” on the other. Inlyta 3 mg is available in blisters of 56 tablets." />
            <manufacturer>
                <reference value="Organization/pfizergermany" />
            </manufacturer>
            <packaging>
                <identifier>
                    <system value="https://spor.ema.europa.eu/pmswi" />
                    <value value="5913fadd-6172-4282-ad02-19ab9d063b66" />
                </identifier>
                <type>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000073497" />
                        <display value="Blister" />
                    </coding>
                </type>
                <quantity value="1" />
                <material>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="200000003215" />
                        <display value="High Density PolyEthylene" />
                    </coding>
                </material>
                <containedItem>
                    <item>
                        <reference>
                            <reference value="ManufacturedItemDefinition/inlyta3mg" />
                        </reference>
                    </item>
                    <amount>
                        <value value="1" />
                        <unit value="mm" />
                        <system value="http://unitsofmeasure.org" />
                        <code value="mg" />
                    </amount>
                </containedItem>
            </packaging>
        </PackagedProductDefinition>
    </resource>
</entry>

<entry>
    <fullUrl value="PackagedProductDefinition/inlyta-5mg-blister-28" />
    <resource>
        <PackagedProductDefinition>
            <id value="inlyta-5mg-blister-28" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi" />
            </meta>
            <identifier>
                <use value="official" />
                <system value="https://spor.ema.europa.eu/pmswi" />
                <value value="b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab" />
            </identifier>
            <name value="Blister of 28 tablets" />
            <type>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="100000155527" />
                    <display value="Chemical Medicinal Product" />
                </coding>
            </type>
            <packageFor>
                <reference value="MedicinalProductDefinition/inlyta-5mg" />
            </packageFor>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="Active" />
                </coding>
            </status>
            <statusDate value="2023-02-17T00:00:00Z" />
            <containedItemQuantity>
                <value value="1" />
                <system value="http://unitsofmeasure.org" />
                <code value="1" />
            </containedItemQuantity>
            <description value="Inlyta 5 mg film-coated tablets are red, oval and debossed with “Pfizer” on one side and “5 XNB” on the other. Inlyta 5 mg is available in blisters of 28 tablets." />
            <manufacturer>
                <reference value="Organization/pfizergermany" />
            </manufacturer>
            <packaging>
                <identifier>
                    <system value="https://spor.ema.europa.eu/pmswi" />
                    <value value="5913fadd-6172-4282-ad02-19ab9d063b66" />
                </identifier>
                <type>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000073497" />
                        <display value="Blister" />
                    </coding>
                </type>
                <quantity value="1" />
                <material>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="200000003215" />
                        <display value="High Density PolyEthylene" />
                    </coding>
                </material>
                <containedItem>
                    <item>
                        <reference>
                            <reference value="ManufacturedItemDefinition/inlyta5mg" />
                        </reference>
                    </item>
                    <amount>
                        <value value="1" />
                        <unit value="mm" />
                        <system value="http://unitsofmeasure.org" />
                        <code value="mg" />
                    </amount>
                </containedItem>
            </packaging>
        </PackagedProductDefinition>
    </resource>
</entry>

<entry>
    <fullUrl value="PackagedProductDefinition/inlyta-5mg-blister-56" />
    <resource>
        <PackagedProductDefinition>
            <id value="inlyta-5mg-blister-56" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi" />
            </meta>
            <identifier>
                <use value="official" />
                <system value="https://spor.ema.europa.eu/pmswi" />
                <value value="b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab" />
            </identifier>
            <name value="Blister of 56 tablets" />
            <type>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="100000155527" />
                    <display value="Chemical Medicinal Product" />
                </coding>
            </type>
            <packageFor>
                <reference value="MedicinalProductDefinition/inlyta-5mg" />
            </packageFor>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="Active" />
                </coding>
            </status>
            <statusDate value="2023-02-17T00:00:00Z" />
            <containedItemQuantity>
                <value value="1" />
                <system value="http://unitsofmeasure.org" />
                <code value="1" />
            </containedItemQuantity>
            <description value="Inlyta 5 mg film-coated tablets are red, oval and debossed with “Pfizer” on one side and “5 XNB” on the other. Inlyta 5 mg is available in blisters of 56 tablets." />
            <manufacturer>
                <reference value="Organization/pfizergermany" />
            </manufacturer>
            <packaging>
                <identifier>
                    <system value="https://spor.ema.europa.eu/pmswi" />
                    <value value="5913fadd-6172-4282-ad02-19ab9d063b66" />
                </identifier>
                <type>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000073497" />
                        <display value="Blister" />
                    </coding>
                </type>
                <quantity value="1" />
                <material>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="200000003215" />
                        <display value="High Density PolyEthylene" />
                    </coding>
                </material>
                <containedItem>
                    <item>
                        <reference>
                            <reference value="ManufacturedItemDefinition/inlyta5mg" />
                        </reference>
                    </item>
                    <amount>
                        <value value="1" />
                        <unit value="mm" />
                        <system value="http://unitsofmeasure.org" />
                        <code value="mg" />
                    </amount>
                </containedItem>
            </packaging>
        </PackagedProductDefinition>
    </resource>
</entry>

<entry>
    <fullUrl value="RegulatedAuthorization/authorization1mg" />
    <resource>
        <RegulatedAuthorization>
            <id value="authorization1mg" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi" />
            </meta>
            <identifier>
                <use value="official" />
                <system value="https://spor.ema.europa.eu/pmswi" />
                <value value="6ae5b5d9-7372-494c-874b-7dc67d386d2e" />
            </identifier>
            <subject>
                <reference value="MedicinalProductDefinition/inlyta-1mg" />
            </subject>
            <type>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="220000000061" />
                    <display value="Marketing Authorisation" />
                </coding>
            </type>
            <region>
                <coding>
                    <system value="urn:iso:std:iso:3166" />
                    <code value="EU" />
                    <display value="European Union" />
                </coding>
            </region>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="Active" />
                </coding>
            </status>
            <statusDate value="2023-02-17T00:00:00Z" />
            <holder>
                <reference value="Organization/PfizerEuropeMAEEIG" />
            </holder>
        </RegulatedAuthorization>
    </resource>
</entry>

<entry>
    <fullUrl value="RegulatedAuthorization/authorization3mg" />
    <resource>
        <RegulatedAuthorization>
            <id value="authorization3mg" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi" />
            </meta>
            <identifier>
                <use value="official" />
                <system value="https://spor.ema.europa.eu/pmswi" />
                <value value="6ae5b5d9-7372-494c-874b-7dc67d386d2e" />
            </identifier>
            <subject>
                <reference value="MedicinalProductDefinition/inlyta-3mg" />
            </subject>
            <type>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="220000000061" />
                    <display value="Marketing Authorisation" />
                </coding>
            </type>
            <region>
                <coding>
                    <system value="urn:iso:std:iso:3166" />
                    <code value="EU" />
                    <display value="European Union" />
                </coding>
            </region>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="Active" />
                </coding>
            </status>
            <statusDate value="2023-02-17T00:00:00Z" />
            <holder>
                <reference value="Organization/PfizerEuropeMAEEIG" />
            </holder>
        </RegulatedAuthorization>
    </resource>
</entry>

<entry>
    <fullUrl value="RegulatedAuthorization/authorization5mg" />
    <resource>
        <RegulatedAuthorization>
            <id value="authorization5mg" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi" />
            </meta>
            <identifier>
                <use value="official" />
                <system value="https://spor.ema.europa.eu/pmswi" />
                <value value="6ae5b5d9-7372-494c-874b-7dc67d386d2e" />
            </identifier>
            <subject>
                <reference value="MedicinalProductDefinition/inlyta-5mg" />
            </subject>
            <type>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="220000000061" />
                    <display value="Marketing Authorisation" />
                </coding>
            </type>
            <region>
                <coding>
                    <system value="urn:iso:std:iso:3166" />
                    <code value="EU" />
                    <display value="European Union" />
                </coding>
            </region>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="Active" />
                </coding>
            </status>
            <statusDate value="2023-02-17T00:00:00Z" />
            <holder>
                <reference value="Organization/PfizerEuropeMAEEIG" />
            </holder>
        </RegulatedAuthorization>
    </resource>
</entry>

<entry>
    <fullUrl value="RegulatedAuthorization/authorization7mg" />
    <resource>
        <RegulatedAuthorization>
            <id value="authorization7mg" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi" />
            </meta>
            <identifier>
                <use value="official" />
                <system value="https://spor.ema.europa.eu/pmswi" />
                <value value="6ae5b5d9-7372-494c-874b-7dc67d386d2e" />
            </identifier>
            <subject>
                <reference value="MedicinalProductDefinition/inlyta-7mg" />
            </subject>
            <type>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="220000000061" />
                    <display value="Marketing Authorisation" />
                </coding>
            </type>
            <region>
                <coding>
                    <system value="urn:iso:std:iso:3166" />
                    <code value="EU" />
                    <display value="European Union" />
                </coding>
            </region>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="Active" />
                </coding>
            </status>
            <statusDate value="2023-02-17T00:00:00Z" />
            <holder>
                <reference value="Organization/PfizerEuropeMAEEIG" />
            </holder>
        </RegulatedAuthorization>
    </resource>
</entry>

<entry>
    <fullUrl value="PackagedProductDefinition/inlyta-7mg-blister-28" />
    <resource>
        <PackagedProductDefinition>
            <id value="inlyta-7mg-blister-28" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi" />
            </meta>
            <identifier>
                <use value="official" />
                <system value="https://spor.ema.europa.eu/pmswi" />
                <value value="b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab" />
            </identifier>
            <name value="Blister of 28 tablets" />
            <type>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="100000155527" />
                    <display value="Chemical Medicinal Product" />
                </coding>
            </type>
            <packageFor>
                <reference value="MedicinalProductDefinition/inlyta-7mg" />
            </packageFor>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="Active" />
                </coding>
            </status>
            <statusDate value="2023-02-17T00:00:00Z" />
            <containedItemQuantity>
                <value value="1" />
                <system value="http://unitsofmeasure.org" />
                <code value="1" />
            </containedItemQuantity>
            <description value="Inlyta 7 mg film-coated tablets are red, oval and debossed with “Pfizer” on one side and “7 XNB” on the other. Inlyta 7 mg is available in blisters of 28 tablets." />
            <manufacturer>
                <reference value="Organization/pfizergermany" />
            </manufacturer>
            <packaging>
                <identifier>
                    <system value="https://spor.ema.europa.eu/pmswi" />
                    <value value="5913fadd-6172-4282-ad02-19ab9d063b66" />
                </identifier>
                <type>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000073497" />
                        <display value="Blister" />
                    </coding>
                </type>
                <quantity value="1" />
                <material>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="200000003215" />
                        <display value="High Density PolyEthylene" />
                    </coding>
                </material>
                <containedItem>
                    <item>
                        <reference>
                            <reference value="ManufacturedItemDefinition/inlyta7mg" />
                        </reference>
                    </item>
                    <amount>
                        <value value="1" />
                        <unit value="mm" />
                        <system value="http://unitsofmeasure.org" />
                        <code value="mg" />
                    </amount>
                </containedItem>
            </packaging>
        </PackagedProductDefinition>
    </resource>
</entry>

<entry>
    <fullUrl value="PackagedProductDefinition/inlyta-7mg-blister-56" />
    <resource>
        <PackagedProductDefinition>
            <id value="inlyta-7mg-blister-56" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi" />
            </meta>
            <identifier>
                <use value="official" />
                <system value="https://spor.ema.europa.eu/pmswi" />
                <value value="b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab" />
            </identifier>
            <name value="Blister of 56 tablets" />
            <type>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="100000155527" />
                    <display value="Chemical Medicinal Product" />
                </coding>
            </type>
            <packageFor>
                <reference value="MedicinalProductDefinition/inlyta-7mg" />
            </packageFor>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="Active" />
                </coding>
            </status>
            <statusDate value="2023-02-17T00:00:00Z" />
            <containedItemQuantity>
                <value value="1" />
                <system value="http://unitsofmeasure.org" />
                <code value="1" />
            </containedItemQuantity>
            <description value="Inlyta 7 mg film-coated tablets are red, oval and debossed with “Pfizer” on one side and “7 XNB” on the other. Inlyta 7 mg is available in blisters of 56 tablets." />
            <manufacturer>
                <reference value="Organization/pfizergermany" />
            </manufacturer>
            <packaging>
                <identifier>
                    <system value="https://spor.ema.europa.eu/pmswi" />
                    <value value="5913fadd-6172-4282-ad02-19ab9d063b66" />
                </identifier>
                <type>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000073497" />
                        <display value="Blister" />
                    </coding>
                </type>
                <quantity value="1" />
                <material>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="200000003215" />
                        <display value="High Density PolyEthylene" />
                    </coding>
                </material>
                <containedItem>
                    <item>
                        <reference>
                            <reference value="ManufacturedItemDefinition/inlyta7mg" />
                        </reference>
                    </item>
                    <amount>
                        <value value="1" />
                        <unit value="mm" />
                        <system value="http://unitsofmeasure.org" />
                        <code value="mg" />
                    </amount>
                </containedItem>
            </packaging>
        </PackagedProductDefinition>
    </resource>
</entry>

<entry>
    <fullUrl value="MedicinalProductDefinition/inlyta-1mg" />
    <resource>
        <MedicinalProductDefinition>
            <id value="inlyta-1mg" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi" />
            </meta>
            <identifier>
                <system value="http://ema.europa.eu/fhir/epiDocument" />
                <value value="471bb15-7f52-4fcd-b615-8674ce6eb91e" />
            </identifier>
            <type>
                <coding>
                    <system value="http://hl7.org/fhir/medicinal-product-type" />
                    <code value="MedicinalProduct" />
                    <display value="Medicinal Product" />
                </coding>
            </type>
            <domain>
                <coding>
                    <system value="http://hl7.org/fhir/medicinal-product-domain" />
                    <code value="Human" />
                    <display value="Human use" />
                </coding>
            </domain>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="active" />
                </coding>
            </status>
            <legalStatusOfSupply>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="100000072084" />
                    <display value="Medicinal product subject to medical prescription" />
                </coding>
            </legalStatusOfSupply>
            <name>
                <productName value="Inlyta® (axitinib) 1 mg film-coated tablets" />
                <part>
                    <part value="Inlyta" />
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/lists/220000000000" />
                            <code value="220000000002" />
                            <display value="Invented name part" />
                        </coding>
                    </type>
                </part>
                <part>
                    <part value="Axitinib" />
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/lists/220000000000" />
                            <code value="220000000003" />
                            <display value="Scientific name part" />
                        </coding>
                    </type>
                </part>
                <part>
                    <part value="1 mg" />
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/lists/220000000000" />
                            <code value="220000000004" />
                        </coding>
                    </type>
                </part>
                <part>
                    <part value="Film-coated tablets" />
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/lists/220000000000" />
                            <code value="220000000005" />
                            <display value="Pharmaceutical dose form part" />
                        </coding>
                    </type>
                </part>
                <usage>
                    <country>
                        <coding>
                            <system value="urn:iso:std:iso:3166" />
                            <code value="EU" />
                            <display value="European Union" />
                        </coding>
                    </country>
                    <jurisdiction>
                        <coding>
                            <system value="urn:iso:std:iso:3166" />
                            <code value="EU" />
                            <display value="European Union" />
                        </coding>
                    </jurisdiction>
                    <language>
                        <coding>
                            <system value="urn:ietf:bcp:47" />
                            <code value="en" />
                            <display value="English" />
                        </coding>
                    </language>
                </usage>
            </name>
        </MedicinalProductDefinition>
    </resource>
</entry>

<entry>
    <fullUrl value="MedicinalProductDefinition/inlyta-3mg" />
    <resource>
        <MedicinalProductDefinition>
            <id value="inlyta-3mg" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi" />
            </meta>
            <identifier>
                <system value="http://ema.europa.eu/fhir/epiDocument" />
                <value value="471bb15-7f52-4fcd-b615-8674ce6eb91e" />
            </identifier>
            <type>
                <coding>
                    <system value="http://hl7.org/fhir/medicinal-product-type" />
                    <code value="MedicinalProduct" />
                    <display value="Medicinal Product" />
                </coding>
            </type>
            <domain>
                <coding>
                    <system value="http://hl7.org/fhir/medicinal-product-domain" />
                    <code value="Human" />
                    <display value="Human use" />
                </coding>
            </domain>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="active" />
                </coding>
            </status>
            <legalStatusOfSupply>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="100000072084" />
                    <display value="Medicinal product subject to medical prescription" />
                </coding>
            </legalStatusOfSupply>
            <name>
                <productName value="Inlyta® (axitinib) 3 mg film-coated tablets" />
                <part>
                    <part value="Inlyta" />
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/lists/220000000000" />
                            <code value="220000000002" />
                            <display value="Invented name part" />
                        </coding>
                    </type>
                </part>
                <part>
                    <part value="Axitinib" />
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/lists/220000000000" />
                            <code value="220000000003" />
                            <display value="Scientific name part" />
                        </coding>
                    </type>
                </part>
                <part>
                    <part value="3 mg" />
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/lists/220000000000" />
                            <code value="220000000004" />
                        </coding>
                    </type>
                </part>
                <part>
                    <part value="Film-coated tablets" />
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/lists/220000000000" />
                            <code value="220000000005" />
                            <display value="Pharmaceutical dose form part" />
                        </coding>
                    </type>
                </part>
                <usage>
                    <country>
                        <coding>
                            <system value="urn:iso:std:iso:3166" />
                            <code value="EU" />
                            <display value="European Union" />
                        </coding>
                    </country>
                    <jurisdiction>
                        <coding>
                            <system value="urn:iso:std:iso:3166" />
                            <code value="EU" />
                            <display value="European Union" />
                        </coding>
                    </jurisdiction>
                    <language>
                        <coding>
                            <system value="urn:ietf:bcp:47" />
                            <code value="en" />
                            <display value="English" />
                        </coding>
                    </language>
                </usage>
            </name>
        </MedicinalProductDefinition>
    </resource>
</entry>

<entry>
    <fullUrl value="MedicinalProductDefinition/inlyta-5mg" />
    <resource>
        <MedicinalProductDefinition>
            <id value="inlyta-5mg" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi" />
            </meta>
            <identifier>
                <system value="http://ema.europa.eu/fhir/epiDocument" />
                <value value="471bb15-7f52-4fcd-b615-8674ce6eb91e" />
            </identifier>
            <type>
                <coding>
                    <system value="http://hl7.org/fhir/medicinal-product-type" />
                    <code value="MedicinalProduct" />
                    <display value="Medicinal Product" />
                </coding>
            </type>
            <domain>
                <coding>
                    <system value="http://hl7.org/fhir/medicinal-product-domain" />
                    <code value="Human" />
                    <display value="Human use" />
                </coding>
            </domain>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="active" />
                </coding>
            </status>
            <legalStatusOfSupply>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="100000072084" />
                    <display value="Medicinal product subject to medical prescription" />
                </coding>
            </legalStatusOfSupply>
            <name>
                <productName value="Inlyta® (axitinib) 5 mg film-coated tablets" />
                <part>
                    <part value="Inlyta" />
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/lists/220000000000" />
                            <code value="220000000002" />
                            <display value="Invented name part" />
                        </coding>
                    </type>
                </part>
                <part>
                    <part value="Axitinib" />
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/lists/220000000000" />
                            <code value="220000000003" />
                            <display value="Scientific name part" />
                        </coding>
                    </type>
                </part>
                <part>
                    <part value="5 mg" />
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/lists/220000000000" />
                            <code value="220000000004" />
                        </coding>
                    </type>
                </part>
                <part>
                    <part value="Film-coated tablets" />
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/lists/220000000000" />
                            <code value="220000000005" />
                            <display value="Pharmaceutical dose form part" />
                        </coding>
                    </type>
                </part>
                <usage>
                    <country>
                        <coding>
                            <system value="urn:iso:std:iso:3166" />
                            <code value="EU" />
                            <display value="European Union" />
                        </coding>
                    </country>
                    <jurisdiction>
                        <coding>
                            <system value="urn:iso:std:iso:3166" />
                            <code value="EU" />
                            <display value="European Union" />
                        </coding>
                    </jurisdiction>
                    <language>
                        <coding>
                            <system value="urn:ietf:bcp:47" />
                            <code value="en" />
                            <display value="English" />
                        </coding>
                    </language>
                </usage>
            </name>
        </MedicinalProductDefinition>
    </resource>
</entry>

<entry>
    <fullUrl value="MedicinalProductDefinition/inlyta-7mg" />
    <resource>
        <MedicinalProductDefinition>
            <id value="inlyta-7mg" />
            <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi" />
            </meta>
            <identifier>
                <system value="http://ema.europa.eu/fhir/epiDocument" />
                <value value="471bb15-7f52-4fcd-b615-8674ce6eb91e" />
            </identifier>
            <type>
                <coding>
                    <system value="http://hl7.org/fhir/medicinal-product-type" />
                    <code value="MedicinalProduct" />
                    <display value="Medicinal Product" />
                </coding>
            </type>
            <domain>
                <coding>
                    <system value="http://hl7.org/fhir/medicinal-product-domain" />
                    <code value="Human" />
                    <display value="Human use" />
                </coding>
            </domain>
            <status>
                <coding>
                    <system value="http://hl7.org/fhir/publication-status" />
                    <code value="active" />
                    <display value="active" />
                </coding>
            </status>
            <legalStatusOfSupply>
                <coding>
                    <system value="https://spor.ema.europa.eu/rmswi" />
                    <code value="100000072084" />
                    <display value="Medicinal product subject to medical prescription" />
                </coding>
            </legalStatusOfSupply>
            <name>
                <productName value="Inlyta® (axitinib) 7 mg film-coated tablets" />
                <part>
                    <part value="Inlyta" />
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/lists/220000000000" />
                            <code value="220000000002" />
                            <display value="Invented name part" />
                        </coding>
                    </type>
                </part>
                <part>
                    <part value="Axitinib" />
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/lists/220000000000" />
                            <code value="220000000003" />
                            <display value="Scientific name part" />
                        </coding>
                    </type>
                </part>
                <part>
                    <part value="7 mg" />
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/lists/220000000000" />
                            <code value="220000000004" />
                        </coding>
                    </type>
                </part>
                <part>
                    <part value="Film-coated tablets" />
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/lists/220000000000" />
                            <code value="220000000005" />
                            <display value="Pharmaceutical dose form part" />
                        </coding>
                    </type>
                </part>
                <usage>
                    <country>
                        <coding>
                            <system value="urn:iso:std:iso:3166" />
                            <code value="EU" />
                            <display value="European Union" />
                        </coding>
                    </country>
                    <jurisdiction>
                        <coding>
                            <system value="urn:iso:std:iso:3166" />
                            <code value="EU" />
                            <display value="European Union" />
                        </coding>
                    </jurisdiction>
                    <language>
                        <coding>
                            <system value="urn:ietf:bcp:47" />
                            <code value="en" />
                            <display value="English" />
                        </coding>
                    </language>
                </usage>
            </name>
        </MedicinalProductDefinition>
    </resource>
</entry>
</Bundle>